CCS offers an extensive list of cell and gene therapy services such as apheresis collection services, cGMP, and more!
Core Facilities are shared resources that integrate CCS's scientific research expertise, facilities, resources, capabilities, and services to provide support to academic institutions and industry.
Historically, cell therapy products have relied on autologous cell donations...
Recent investment in CAR-T cell therapy has increased the number of studies underway, providing new avenues of development.
Cell therapy continues to evolve, yet CCS remains a major player in the cell therapy and cellular apheresis space.
Reach out via phone, email, or by submitting an inquiry and a team member will follow-up promptly.